The alcohol flush is a genetic warning light for oesophageal cancer, not just a red face

For a large share of people of East Asian descent, a couple of drinks brings on a hot, red flush in the face and neck. It is usually treated as a harmless quirk, or an inconvenience. It is neither. The flush is the outward sign of a genetic enzyme deficiency that, in people who keep drinking, raises the risk of oesophageal cancer sharply — and the link is not widely known, even among those it affects.

The chemistry behind the flush

When the body processes alcohol, an enzyme called alcohol dehydrogenase first converts ethanol into acetaldehyde, a compound that damages DNA and is classed as an animal carcinogen [s1]. A second enzyme, ALDH2, normally clears acetaldehyde quickly by converting it to harmless acetate [s1].

In many East Asian populations, a common gene variant changes a single building block of ALDH2 — replacing glutamate with lysine at one position — and the resulting enzyme does not work [s1]. People who carry one copy of this inactive variant clear acetaldehyde poorly, so it accumulates when they drink [s1]. The flush is that accumulation made visible: the red face, warmth and palpitations are the surface signs of a carcinogen building up in the body [s1].

The scale is large. The review estimates there are at least 540 million people worldwide with ALDH2 deficiency — roughly 8% of the global population — and that about 36% of East Asians (Japanese, Chinese and Korean people) show the characteristic flushing response [s1].

The cancer risk is not subtle

The consequence is a steep increase in oesophageal cancer risk among carriers who drink. Across studies, the review reports odds ratios ranging from 3.7 to 18.1 for oesophageal cancer in ALDH2-deficient drinkers after adjusting for how much they drank, with most studies showing odds ratios above 10 for heterozygous carriers who are heavy drinkers [s1]. For future cancers of the upper aerodigestive tract more broadly, the relative hazard in low-activity ALDH2 heterozygotes runs about 12 times higher [s1].

The review makes the population implication explicit: a strikingly high proportion — 58% to 69% — of the excess oesophageal cancer risk in these carriers is attributable to their drinking [s1]. In other words, the danger is not the genotype alone but the genotype combined with alcohol, which means it is largely avoidable.

Where this fits in the global picture

Oesophageal cancer is already the single largest contributor to the worldwide cancer burden attributable to alcohol. A Lancet Oncology analysis estimated 189,700 alcohol-attributable oesophageal cancer cases globally in 2020, and found the highest regional attributable fraction — 5.7% of all cancers — in eastern Asia, precisely where the inactive ALDH2 variant is most common [s2]. The genetic story and the population story point at the same place.

Why it stays under-recognised

The flush is easy to dismiss because it is common, visible and non-fatal in the moment. Some people even take antihistamines or other agents to suppress the reddening so they can keep drinking — which does nothing about the underlying acetaldehyde accumulation and may mask the body's own warning [s1]. The review's framing is that the flushing response is an unrecognised risk factor precisely because it is treated as cosmetic rather than as a marker of elevated cancer risk [s1].

The limits

The evidence base is largely observational — case-control and cohort studies — so it establishes a strong and consistent association rather than proving causation in the way a trial would, though the clear biological mechanism makes the causal reading persuasive [s1]. The odds ratios vary widely across studies and populations, and apply most strongly to heavy-drinking carriers [s1]. The global cancer figures are modelled estimates with their own uncertainty [s2]. What the evidence supports is that for the hundreds of millions of people who flush, alcohol carries a specific, elevated and largely avoidable oesophageal cancer risk that the flush itself is signalling [s1][s2].

This article describes what the research found. It is not medical advice, and questions about personal cancer risk belong with a clinician.

Sources

• The Alcohol Flushing Response: An Unrecognized Risk Factor for Esophageal Cancer from Alcohol Consumption — PLoS Medicine, 2009-03-24
• Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study — The Lancet Oncology, 2021-07-30